Ovarian Cancer
Conditions
Interventions
Case:neoadjuvant chemotherapy plus intermediate debulking surgery
Control:neoadjuvant chemotherapy plus intermediate debulking surgery
Sponsors
Obstetrics and Gynecology Hospital of Fudan University
Eligibility
Sex/Gender
Female
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1) The patients initially diagnosed with IVB stage epithelial malignant ovarian tumor were by clinical manifestations, physical examination and imaging examination; 2) Before this study, the patient did not receive any surgical treatment related to the disease; 3) No operative contraindications were found; 4) Patient must have signed the informed consent;
Exclusion criteria
Exclusion criteria: 1) The patients with IVB stage epithelial ovarian cancer only had liver, spleen and intestinal parenchymal metastasis, but no extraabdominal organ metastasis; 2) The patient was in a life-threatening emergency state; 3) Combined with other malignant diseases; 4) The informed consent can not be signed due to other reasons, and there is no other guardian agent; 5) Mental illness or unable to cooperate with the trial; 6) The patients whose family members ask to conceal their condition; 7) Patients who can not achieve satisfactory tumor reduction surgery; 8) The patients who also participated in other clinical trials;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1-year progression-free survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| 1-year overall-survival rate; | — |
Countries
China
Contacts
Public ContactLiangqing Yao
Obstetrics and Gynecology Hospital of Fudan University
Outcome results
None listed